Raising awareness of chronic kidney disease in a Brazilian urban population

References1. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-340.2. Atthobari J, Gansevoort RT, Visser ST, de Jong PE, de Jong-van den Berg LT. The effect of screening for cardiorenalrisk factors on drug use in the general population. Br J Clin Pharmacol 2007; 64: 810-818.3. Otero A, Gayoso P, Garcia F, de Francisco AL. Epidemiology of chronic renal disease in the Galician population:results of the pilot Spanish EPIRCE study. Kidney Int Suppl 2005; S16-S19.4. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, et al. International comparison of the relationshipof chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275-2284.5. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidneyfunction in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003;41: 1-12.6. Cusumano AM, Di Gioia C, Hermida O, Lavorato C. The Latin American Dialysis and Renal Transplantation RegistryAnnual Report 2002. Kidney Int Suppl 2005; S46-S52.7. Dirks JH, Robinson S, Burdmann E, Correa-Rotter R, Mezzano S, Rodriguez-Iturbe B. Prevention strategies forchronic kidney disease in Latin America: a strategy for the next decade - a report on the Villarica Conference. Ren Fail2006; 28: 611-615.8. Passos VM, Barreto SM, Lima-Costa MF. Detection of renal dysfunction based on serum creatinine levels in a Braziliancommunity: the Bambui Health and Ageing Study. Braz J Med Biol Res 2003; 36: 393-401.9. Oliveira MB, Romao JE Jr, Zatz R. End-stage renal disease in Brazil: epidemiology, prevention, and treatment. Kidney Int Suppl 2005; S82-S86.10. Plata R, Silva C, Yahuita J, Perez L, Schieppati A, Remuzzi G. The first clinical and epidemiological programme on renaldisease in Bolivia: a model for prevention and early diagnosis of renal diseases in the developing countries. Nephrol Dial Transplant 1998; 13: 3034-3036.11. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63: 1468-1474.12. Schieppati A, Perico N, Remuzzi G. Preventing end-stage renal disease: the potential impact of screening and interventionin developing countries. Kidney Int 2003; 63: 1948- 1950.13. Schoolwerth AC, Engelgau MM, Hostetter TH. A public health action plan is needed for chronic kidney disease. Adv Chronic Kidney Dis 2005; 12: 418-423.14. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascularevents, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-426.15. Agewall S, Wikstrand J, Ljungman S, Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortalityin treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 1997; 80: 164-169.16. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Proteinuria predicts stroke and other atheroscleroticvascular disease events in nondiabetic and non-insulin- dependent diabetic subjects. Stroke 1996; 27: 2033-2039.17. Culleton BF, Larson MG, Parfrey PS, Kannel WB, Levy D. Proteinuria as a risk factor for cardiovascular disease andmortality in older people: a prospective study. Am J Med 2000; 109: 1-8.18. Brantsma AH, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT. Extended prognostic value of urinary albuminexcretion for cardiovascular events. J Am Soc Nephrol 2008; 19: 1785-1791.19. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA 2003; 290: 3101-3114.20. Santa Cruz F, Cabrera W, Barreto S, Mayor MM, Baez D. Kidney disease in Paraguay. Kidney Int Suppl 2005; S120- S125.21. Topham PS, Jethwa A, Watkins M, Rees Y, Feehally J. The value of urine screening in a young adult population. Fam Pract 2004; 21: 18-21